A recent article in the Canadian Medical Association Journal by Dr D Simmons highlights the importance of intensive, ongoing support to women who develop gestational diabetes. Key points from the article are:

GPs can now participate in a paper-less NPS Clinical e-Audit that:

gives immediate patient-specific feedback on best practice clinical indicators

assists with implementing changes in practice to improve patient care.

One of the first GPs to test the audit and remarked that “this is a lot better ...

Date: Monday 25th August 2008

Time: 6:30—9:00pm

Location: Gemini Hotel, Griffith

Medicare Australia is working in partnership with key stakeholders to increase awareness and correct use of MBS items relating to Chronic Disease Management (CDM) among GPs, practice staff and eligible allied health professionals.

In the next week information packs will be sent to GP practice st...

The first of a new class of oral drugs for improving glycaemic control in type 2 diabetes, has been published online today. Sitagliptin is PBS-listed for dual oral therapy with either metformin or a sulfonylurea, when a combination of these drugs is contraindicated or not tolerated.

A new drug in a...

To help prescribers and pharmacists counsel patients concerned about the sleep-related adverse effects associated with zolpidem (Stilnox), the National Prescribing Service Limited (NPS) has today released a position statement on the drug and sleep-related behaviours. The position statement explains ...

Since 1 July 2008, new MBS items have been introduced for consultant paediatricians and psychiatrists and allied health providers to enable the diagnosis and treatment of children with pervasive developmental disorders (PDD) including autism. GPs have a crucial role in enabling access to these new M...